A study from the US Diabetes Prevention Program reveals that lifestyle changes, including exercise and a healthy diet, are ...

Daily metformin use in the month before pregnancy is associated with more than 70% reduction in risk for hyperemesis ...

Caffeine activates cell survival pathways in yeast, potentially slowing aging through energy and stress responses.

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.

Shed, a modern wellness company focused on helping individuals feel and function their best, announces the launch of several ...